[Study on the effect of realgar nanoparticles on reducing the respiratory syncytial virus type A (RSV-a) replication in vitro].

Miao Cheng(Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine), Wenbo Xu(Shenyang Institute of Automation), Yan Zhang(German Cancer Research Center), Mingzhe Wang(Tsinghua–Berkeley Shenzhen Institute), Cheng‐Xiang Wang(Southeast University), Hui‐Fang Wang(Xi'an Jiaotong University), Zhen Zhu, Honglan Zhao, Bao‐Di Gou

PubMed

January 1, 2012

Cited by 0

|New England Journal of Medicine|2020|30.5k

|The Lancet|2020|12.6k

|Science China Information Sciences|2020|1.9k

|IEEE Communications Surveys & Tutorials|2023|1.9k

|Nature|2020|1.2k

Related Papers